Exploring the mental health challenges faced by females with polycystic ovary syndrome (PCOS)

Abstract

Polycystic Ovary Syndrome (PCOS) is a prevalent endocrine disorder affecting about 6-10% of females of reproductive age worldwide. Characterized by hyperandrogenism, anovulation, and polycystic ovarian morphology, PCOS is animportantreason of sterility and is associated with long-term health risks such as type 2 diabetes, heart problems, and metabolic syndrome. In spite of extensive research, the etiology of PCOS remains multifactorial, involving genetic predisposition, insulin resistance, and environmental factors. Females with PCOS often experience a range of physical symptoms, comprising obesity, acne, and hirsutism, which contribute to important mental distress, including anxiety, depression and abridged quality of life. Treatment approaches are individualized, addressing symptoms and associated risks through lifestyle interventions and pharmacological treatments. Given the rising recognition of PCOS as a public health concern, ongoing research is vital to improve our understanding of its pathophysiology and to develop more effective management strategies, particularly in the domains of psychological wellbeing and overall quality of life for affected females.